Biotechnology Industry Research Assistance Council Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.00 Cr
as on 23-10-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -13.45%
(FY 2023)
- Profit 0.62%
(FY 2023)
- Ebitda 13.75%
(FY 2023)
- Net Worth 8.91%
(FY 2023)
- Total Assets -50.39%
(FY 2023)
About Biotechnology Industry Research Assistance Council
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biotechnology Industry Research Assistance Council India is Kavita Anandani as COMPANY SECRETARY. Rajesh Gokhale, Vishvajit Sahay, Jitendra Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100DL2012NPL233152
- Company No.
233152
- Company Classification
Private Not For Profit Company
- Incorporation Date
20 Mar 2012
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biotechnology Industry Research Assistance Council?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jitendra Kumar | Managing Director | 09-Jun-2023 | Current |
Kavita Anandani | Company Secretary | 01-Jul-2014 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nidhi Shrivastava | Whole-Time Director | 15-Dec-2021 | Current |
Rajesh Gokhale | Director | 01-Nov-2021 | Current |
Vishvajit Sahay | Nominee Director | 24-Dec-2020 | Current |
Krishna Penna | Director | 27-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Biotechnology Industry Research Assistance Council.
Biotechnology Industry Research Assistance Council, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.45% decrease. The company also saw a slight improvement in profitability, with a 0.62% increase in profit. The company's net worth moved up by a moderate rise of 8.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biotechnology Industry Research Assistance Council?
In 2023, Biotechnology Industry Research Assistance Council had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotechnology Industry Research Assistance Council?
Biotechnology Industry Research Assistance Council has a workforce of 75 employees as of Oct 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotechnology Industry Research Assistance Council, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotechnology Industry Research Assistance Council's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.